Adverse events · Adults with cancer receiving treatment
1 finding from 1 review
Adverse events attributed to KGF were typically oral-related or skin-related; mostly mild to moderate with very few serious events; reporting poor and inconsistent, not appropriate to meta-analyse (SoF comments cell,…
16 studies
GRADE not reported
Adverse events · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
1 finding from 1 review
In one study, one participant (<1%) in the paracetamol group experienced drug hypersensitivity (a 'red, blotchy and itchy rash') that resolved without treatment within 1 week (Bradley 2007 / McAlinden 2005); 1 RCT;…
1 study
Very low
Adverse events · Adults with cancer receiving treatment
1 finding from 1 review
Adverse events · Adults receiving chemotherapy alone for colorectal cancer
1 finding from 1 review
Adverse events · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · Adults with cancer receiving treatment
1 finding from 1 review
Adverse events · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events · Patients with collagenous colitis
Budesonide showed no clear difference in serious adverse events compared with mesalazine (low certainty).
1 finding from 1 review
Adverse events · Patients with collagenous colitis
Mesalamine showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events · Patients with collagenous colitis
Mesalamine showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · Patients with collagenous colitis
It is very uncertain whether mesalazine changes adverse events compared with mesalazine + cholestyramine (very low certainty).
1 finding from 1 review
Adverse events · Patients with collagenous colitis
It is very uncertain whether probiotics changes adverse events compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · Patients with collagenous colitis
Budesonide showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events · Patients with collagenous colitis
It is very uncertain whether budesonide changes serious adverse events compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · Patients with collagenous colitis
Boswellia serrata extract showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · Patients with collagenous colitis
Budesonide showed no clear difference in adverse events compared with mesalazine (low certainty).
1 finding from 1 review
Adverse events · patients with active lymphocytic colitis
Budesonide showed no clear difference in adverse events compared with mesalazine (low certainty).
1 finding from 1 review
Adverse events · children/young people aged 4‐18 years with traumatic brain injury and with 'mild to severe spastic tetraparesis' (weakness) in all limbs
1 finding from 1 review
Adverse events · adults with traumatic brain injury with spasticity in their arms and legs
1 finding from 1 review
Adverse events · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
1 finding from 1 review